[Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
In a single-center, double-blind, randomized study, 19 patients with peripheral arterial occlusive disease stage II Fontaine were treated with bencyclan, and a further 19 patients with buflomedil for 10 weeks after a wash-out phase of 2 weeks. Both groups showed a significant increase in painfree and total walking distances. No significant difference was found between the two groups.
Trübestein
G
G
Trübestein
R
R
Ludwig
M
M
D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001537:Bencyclane / Q000008:administration & dosage*; D003508:Cycloheptanes / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007511:Ischemia / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D011759:Pyrrolidines / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D014665:Vasodilator Agents / Q000008:administration & dosage
D003508:Cycloheptanes; D011759:Pyrrolidines; D014665:Vasodilator Agents; D001537:Bencyclane; C010651:buflomedil
Bencyclan bei arterieller Verschlusskrankheit im Stadium II. Ergebnisse einer kontrollierten Studie.